CMND - CIK 0001892500
The table below shows Clearmind Medicine Inc.'s balance sheet line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash & equivalents | - | - | - |
| Short-term investments | - | - | - |
| Receivables | - | - | - |
| Inventory | - | - | - |
| Total current assets | - | - | - |
| Property, plant & equipment | - | - | - |
| Goodwill | - | - | - |
| Total assets | $6.08M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.26M |
| $5.95M |
| Accounts payable | - | - | - |
| Total current liabilities | - | - | - |
| Long-term debt | - | - | - |
| Total liabilities | $4.89M | $4.15M | $4.97M |
| Retained earnings | - | - | - |
| Total equity | - | - | - |